Last update:

Weight management news

Experimental obesity drug targets appetite through amylin, offering potential alternative to GLP-1 therapies

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), and published in The Lancet Diabetes & Endocrinology shows that weekly injections ...

Higher GLP-1 costs lead to lower adherence

Semaglutides, or GLP-1s, can produce substantial weight loss if individuals adhere to their doctor's instructions. But a new study from the University of Georgia suggests patients aren't taking the weight loss medication ...

Q&A: What are ultra-processed foods?

Nearly every day, there's a headline about ultra-processed foods, which have been linked to harmful health effects despite lacking a universally accepted definition. These foods are the subject of numerous proposed regulations, ...